Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer. Kariri Y, Toss MS, Alsaleem M, Elsharawy KA, et al. Breast Cancer Res Treat 2022 Feb 6. pii: 10.1007/s10549-022-06531.

Read + Share

Amedeo Smart

Independent Medical Education

Kariri Y, Toss MS, Alsaleem M, Elsharawy KA, et al. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer. Breast Cancer Res Treat 2022 Feb 6. pii: 10.1007/s10549-022-06531.
PMID: 35124721